申请人:Sandoz Ltd.
公开号:US05071871A1
公开(公告)日:1991-12-10
New benz[b]pyranes and pyranopyridines of formula I, ##STR1## wherein the significances of substituents V, T, W, R.sub.3 to R.sub.5, R.sub.9, R.sub.10, m, X, Y and Z are given in claim 1 and their N-oxides and their salts and their use in the treatment of raised blood pressure in the treatment of vascular disorders and other disorders in which a reduction in tension of the smooth muscles is therapeutically useful, as well as in the treatment of hair loss and baldness. Further the compounds are useful in the treatment of asthma and obstructive disorders of the respiratory system as well as in the prophylactic treatment of obstructive or inflammatory airways disease, for example asthma, as well as novel pharmaceutical compositions comprising said K.sup.+ channel activators suitable for such use.
新的苯并[b]吡喃和吡喃吡啶化合物的化学式I如下:##STR1## 其中取代基V、T、W、R.sub.3至R.sub.5、R.sub.9、R.sub.10、m、X、Y和Z的意义在权利要求书1中给出,以及它们的N-氧化物和盐以及它们在治疗高血压、血管紊乱和其他需要治疗平滑肌张力降低的疾病,以及在治疗脱发和秃发方面的用途。此外,该化合物对哮喘和呼吸系统阻塞性疾病的治疗也很有用,以及在预防阻塞性或炎性气道疾病,例如哮喘方面的预防性治疗中,包括所述K.sup.+通道激活剂的新型制药组合物适用于此类用途。